Cargando…

The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is one of the hepatic disorders which is characterized by increasing fat deposits in the liver. This disorder may lead to elevation the activity of liver enzymes and is associated with obesity, dyslipidemia, hypertension, and type II diabetes. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Afsharinasab, Mehdi, Mohammad-Sadeghipour, Maryam, Reza Hajizadeh, Mohammad, Khoshdel, Alireza, Mirzaiey, Vahid, Mahmoodi, Mehdi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384360/
https://www.ncbi.nlm.nih.gov/pubmed/32742180
http://dx.doi.org/10.1016/j.sjbs.2020.04.037
_version_ 1783563596667551744
author Afsharinasab, Mehdi
Mohammad-Sadeghipour, Maryam
Reza Hajizadeh, Mohammad
Khoshdel, Alireza
Mirzaiey, Vahid
Mahmoodi, Mehdi
author_facet Afsharinasab, Mehdi
Mohammad-Sadeghipour, Maryam
Reza Hajizadeh, Mohammad
Khoshdel, Alireza
Mirzaiey, Vahid
Mahmoodi, Mehdi
author_sort Afsharinasab, Mehdi
collection PubMed
description BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is one of the hepatic disorders which is characterized by increasing fat deposits in the liver. This disorder may lead to elevation the activity of liver enzymes and is associated with obesity, dyslipidemia, hypertension, and type II diabetes. The aim of present study was to investigate the effect of Berberis integerrima extract on NAFLD patients compare to placebo. METHODS: The present clinical trial was performed on 42 NAFLD patients who were randomly divided into two groups. The case group received a capsule (750 mg) containing hydro-alcoholic extract of Berberis integerrima extract every 12 h for 2 months, while the control (placebo) group received a capsule containing cellulose. Baseline characteristics, biochemical factors, antioxidant parameter, functional liver and renal test were evaluated before and after the treatment. RESULTS: Comparison rate of different parameters in case group before and after treatment demonstrated that BMI, cholesterol, triglyceride, LDL-C, fasting blood glucose, liver enzymes and renal parameters such as aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase were significantly decreased while HDL-C, glutathione peroxidase enzyme, and total antioxidant capacity were significantly elevated. The comparison of the mean parameters difference in two groups indicated that cholesterol, triglyceride, LDL-C, fasting blood glucose, liver enzymes and renal factors were significantly decreased, however HDL-C, glutathione peroxidase enzyme, and total antioxidant capacity were significantly increased in case group compared to control group. CONCLUSION: The study findings revealed that the Berberis integerrima extract could reduce biochemical factors of blood, except HDL-C and increases total antioxidant capacity and glutathione peroxidase enzyme. Therefore, hydro-alcoholic extract of Berberis integerrima may be used as a great supplementary medicine in treating NAFLD.
format Online
Article
Text
id pubmed-7384360
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-73843602020-07-30 The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease Afsharinasab, Mehdi Mohammad-Sadeghipour, Maryam Reza Hajizadeh, Mohammad Khoshdel, Alireza Mirzaiey, Vahid Mahmoodi, Mehdi Saudi J Biol Sci Article BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is one of the hepatic disorders which is characterized by increasing fat deposits in the liver. This disorder may lead to elevation the activity of liver enzymes and is associated with obesity, dyslipidemia, hypertension, and type II diabetes. The aim of present study was to investigate the effect of Berberis integerrima extract on NAFLD patients compare to placebo. METHODS: The present clinical trial was performed on 42 NAFLD patients who were randomly divided into two groups. The case group received a capsule (750 mg) containing hydro-alcoholic extract of Berberis integerrima extract every 12 h for 2 months, while the control (placebo) group received a capsule containing cellulose. Baseline characteristics, biochemical factors, antioxidant parameter, functional liver and renal test were evaluated before and after the treatment. RESULTS: Comparison rate of different parameters in case group before and after treatment demonstrated that BMI, cholesterol, triglyceride, LDL-C, fasting blood glucose, liver enzymes and renal parameters such as aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase were significantly decreased while HDL-C, glutathione peroxidase enzyme, and total antioxidant capacity were significantly elevated. The comparison of the mean parameters difference in two groups indicated that cholesterol, triglyceride, LDL-C, fasting blood glucose, liver enzymes and renal factors were significantly decreased, however HDL-C, glutathione peroxidase enzyme, and total antioxidant capacity were significantly increased in case group compared to control group. CONCLUSION: The study findings revealed that the Berberis integerrima extract could reduce biochemical factors of blood, except HDL-C and increases total antioxidant capacity and glutathione peroxidase enzyme. Therefore, hydro-alcoholic extract of Berberis integerrima may be used as a great supplementary medicine in treating NAFLD. Elsevier 2020-08 2020-04-25 /pmc/articles/PMC7384360/ /pubmed/32742180 http://dx.doi.org/10.1016/j.sjbs.2020.04.037 Text en © 2020 Published by Elsevier B.V. on behalf of King Saud University. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Afsharinasab, Mehdi
Mohammad-Sadeghipour, Maryam
Reza Hajizadeh, Mohammad
Khoshdel, Alireza
Mirzaiey, Vahid
Mahmoodi, Mehdi
The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease
title The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease
title_full The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease
title_fullStr The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease
title_full_unstemmed The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease
title_short The effect of hydroalcoholic Berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease
title_sort effect of hydroalcoholic berberis integerrima fruits extract on the lipid profile, antioxidant parameters and liver and kidney function tests in patients with nonalcoholic fatty liver disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7384360/
https://www.ncbi.nlm.nih.gov/pubmed/32742180
http://dx.doi.org/10.1016/j.sjbs.2020.04.037
work_keys_str_mv AT afsharinasabmehdi theeffectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease
AT mohammadsadeghipourmaryam theeffectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease
AT rezahajizadehmohammad theeffectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease
AT khoshdelalireza theeffectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease
AT mirzaieyvahid theeffectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease
AT mahmoodimehdi theeffectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease
AT afsharinasabmehdi effectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease
AT mohammadsadeghipourmaryam effectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease
AT rezahajizadehmohammad effectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease
AT khoshdelalireza effectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease
AT mirzaieyvahid effectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease
AT mahmoodimehdi effectofhydroalcoholicberberisintegerrimafruitsextractonthelipidprofileantioxidantparametersandliverandkidneyfunctiontestsinpatientswithnonalcoholicfattyliverdisease